Smart-Money SignalNeutral · 53/100— Insiders are net buyers over 90 days ($1.1M, 12 buys vs 3 sales)
Revenue$34.5M
Net Income-$10.8M
EPS$-0.16
Gross Margin46.9%
Market Cap$112.0M
Price Performance
Historical data including institutional events
Company Profile
K
Keith J. Sullivan
CEO & Executive Director
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
